Procter & Gamble Health Ltd.'s share price declined 6% to a low of Rs 6,070 in trade on Thursday, despite net profit and revenue for the first quarter of financial year 2027 jumping.
P&G Health reported a 45.5% year-on-year rise in net profit to Rs 96 crore from Rs 66 crore for the June quarter on strengthened supply chain and go-to-market capabilities, and one-time proceeds from the sale of an immovable asset.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Operational Profit After Tax (PAT) was Rs 72 crores, up 9% versus a year ago excluding the one-time proceeds. Revenue increased 7.4% to Rs 364 crore from Rs 339 crore, while Ebitda rose 11% to Rs 101 crore from Rs 91 crore.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
ALSO READ: Suven Life Sciences Shares Decline Over 5% As Q1 Net Loss Widens To Rs 128 Crore
The company's Ebitda margin expanded to 27.7% from 26.8% in the corresponding quarter last year.
"We are delivering balanced growth and value creation for all our stakeholders, driven by our strategy that is centred on a focused portfolio of quality, trusted and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption, productivity, and an agile accountable organization," Milind Thatte, Managing Director, P&G Health India said while commenting on the performance.
As of 3 p.m. IST, the stock traded 5.33% lower at Rs 6,122.50, as against a marginal advance in the benchmark Nifty index. The share price has risen 6.9% year-to-date and 0.89% in the last 12 months.
ALSO READ: Bajaj Electricals Share Price Jumps 16% After Q1 Profit Swells, Margin Surges
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
